Background. Enterohemorrhagic Escherichia coli (EHEC) cause most cases of the hemolytic uremic syndrome (HUS) worldwide. To investigate genetic changes in EHEC during the course of human infection, we analyzed consecutive stool samples and shed isolates from patients with HUS, focusing on the genes encoding Shiga toxin (stx) and intimin (eae).
(Stx) 1, Stx2, or Stx2c, either singly or in combinations [2, 5, 6, 9, 10] . Stxs are believed to be the major precipitants of the microvascular thrombi that form the histopathological basis of HUS [11] . However, EHEC also produce factors other than Stx that can contribute to the pathogenesis of HUS [12] . Candidates for such non-Stx putative virulence factors include the EHEC pore-forming hemolysin [13] and intimin, encoded by eae [14] . Intimin mediates intimate attachment to epithelial cells in vitro and in animal models [15, 16] , and it is found in almost all EHEC strains from patients with HUS [5, 6] . Enteropathogenic E. coli (EPEC) share intimin with the most common varieties of EHEC but lack Stx [17] . Many of the potential pathogenicity factors of EHEC are encoded by mobile genetic elements, such as plasmids, pathogenicity islands, and bacteriophages [12] . The association between DNA transfer and virulence is well documented [18] . The stx genes in EHEC are encoded on temperate lambdoid bacterio-phages [19, 20] and can be eliminated from such strains by inducing the stx-converting phages with sublethal doses of UV light, mitomycin C, or various antibiotics [19, 21, 22] .
Little is known about genetic changes sustained by EHEC during human infection. Therefore, in this study, we investigated genetic changes of EHEC strains during the course of HUS. To accomplish this aim, we analyzed consecutive stool samples obtained from patients with HUS with use of molecular detection of stx and eae genes to identify strains that were stx positive and eae positive (stx+/eae+ strains) and strains that were stx negative and eae positive (stxϪ/eae+ strains). We compared isolates from consecutive stool samples of the same patient with regard to extended virulence profiles, plasmid profiles, and PFGE patterns. Also, we investigated molecular and phenotypic characteristics that can be used for the laboratory diagnosis of both stx+ and stxϪ E. coli strains associated with HUS.
PATIENTS AND METHODS

Patients.
During routine diagnostic efforts conducted between 1996 and 2003, sequentially collected stool samples from 210 patients with HUS were investigated for the presence of E. coli strains harboring stx and/or eae genes. The patients were from different regions of Germany, and, except for 3 who were part of a small outbreak of HUS [23] , none showed temporal or geographical linkage. HUS was defined as a case of microangiopathic hemolytic anemia (i.e., hematocrit !30% with peripheral evidence of intravascular hemolysis), thrombocytopenia (i.e., platelet count !150,000 platelets/mm 3 ), and renal insufficiency (i.e., serum creatinine concentration greater than the upper limit of the normal range for age) [24] . The initial stool samples were collected 5-14 days after the onset of prodromal diarrhea (median interval, 9 days), which corresponds to the early HUS phase of the illness. The follow-up stool samples were collected 3-16 days later (median interval, 8 days).
Stool sample analysis. Stx in stool filtrates was detected using the Vero cell cytotoxicity assay [25] . Screening for and isolation of E. coli strains harboring target loci were performed as described elsewhere [5] . In brief, enriched stool samples were analyzed for E. coli O157 by immunomagnetic separation technique and culture of magnetically separated organisms on sorbitol MacConkey (SMAC) agar and cefixime-tellurite SMAC agar. To identify non-O157 stx+ or eaeϪ E. coli strains, 200 mL of the enrichment broth was cultured on SMAC agar and enterohemolysin agar [13] . The overnight bacterial growth was harvested into 1 mL of saline, and ∼10 6 cells were used in PCR with primer pairs KS7-KS8 [26] , LP43-LP44 [27] , and SK1-SK2 [26] , which are specific for stx 1 , stx 2 , and eae, respectively. To isolate strains from samples with positive PCR results, bacterial suspensions were diluted and restreaked on SMAC plates to obtain 300-400 separated colonies. The colonies were transferred in parallel to 3 nylon membranes (Zeta-probe GT; BioRad) that were subsequently hybridized with digoxigenin-labeled stxB 1 , stxA 2 , or eae probes [26] . The hybridizing colonies were subsequently isolated from the original SMAC plates.
Detection of other enteric bacterial pathogens in stool samples. Salmonella species, Shigella species, Yersinia enterocolitica, and Campylobacter jejuni were sought using standard procedures.
Serological investigation. Purification of lipopolysaccharides (LPSs) O26 and O157 and the detection of IgM antibodies against these LPSs in serum samples obtained during the acute phase of HUS were performed as described elsewhere [28] .
Phenotyping methods. Isolates were serotyped using a microtiter method [29] . Biochemical identification was performed with API 20 E (bioMérieux). In addition, sorbitol fermentation was detected on SMAC agar. Stx production was tested using a latex agglutination assay [30] . The enterohemolytic phenotype was sought on enterohemolysin agar [13, 31] .
Genotyping methods. The PCR strategy to detect stx was described elsewhere [5, 32, 33] . Detection and characterization of eae was performed as described elsewhere [26, 34, 35] . The EHEC hemolysin gene (EHEC-hlyA) and the sfpA gene [36] were detected using primer pairs hlyA1-hlyA4 [13] and sfpA-U-sfpA-L [37] , respectively. The cytolethal distending toxin (CDT)-V gene cluster was detected as described elsewhere [38] . E. coli O157:H7 strain EDL933 [39] , E. coli O26:NM strain 5720/96 [10] , and SF E. coli O157:NM strain 493/89 [38] were used as positive controls in PCRs. fliC restriction fragmentlength polymorphism (RFLP) analysis was performed as described elsewhere [40] .
Plasmid profiles and PFGE analysis. Plasmid profiles were determined as described elsewhere [9] . PFGE was performed using XbaI-digested genomic DNA from Salmonella braenderup strain H9812 (Centers for Disease Control and Prevention) as a size marker [41] . Restriction fragment patterns of genomic DNA were analyzed with BioNumerics software, version 4.0 (Applied Maths BVBA) and analyzed with the criteria of Tenover et al. [42] .
Statistical analysis. Statistical analysis was performed using 2-tailed Fisher's exact test. P values !.05 were considered to be statistically significant.
RESULTS
Analysis of initial stool specimens from patients with HUS for stx+ and/or eae+ E. coli. Initial cultures of stool samples from 137 of 210 patients with HUS were positive for stx and eae genes (table 1) . From the initial stool cultures for 2 patients that tested positive for stx but not eae, stx+/eaeϪ strains of serotypes O91:H21 and O113:H21 were isolated. Stool cultures from 5 additional patients were eae+ and stxϪ. Fecal filtrates from 2 patients in which neither stx+ nor eaeϪ strains were detected were found to contain Stx activity. In all other patients, the Vero cell assay and genetic analysis agreed (table 1) . Stools from all patients were negative for Salmonella species, Shigella species, Yersinia enterocolitica, and Campylobacter jejuni. Follow-up stool analysis. To determine whether the pathogen population changes over time within individual patients, we analyzed follow-up stool samples. In 1 of the 64 subjects with neither stx-and/or eae-harboring E. coli nor detectable Stx activity in their initial stools, an stx-positive, eae-positive E. coli O157:H7 strain was subsequently identified (table 1) , suggesting intermittent shedding. The 5 patients shedding stxϪ/ eae+ E. coli strains in their initial stools had identical strains at follow-up (table 1) . Of the 137 patients who had stx-and eae-positive strains in their initial stools, only 12 (8.8%) shed the infecting strains in follow-up stools. In 118 patients (86.1%), the follow-up stool samples were negative for stx 1 , stx 2 and eae genes by PCR screening and contained no free Stx, as detected by the Vero cell cytotoxicity assay (table 1). In the remaining 7 patients who shed stx+/eae+ strains of serotypes O26:H11/NM (6 patients) or O157:NM (1 patient) in their initial stool samples, the follow-up stool samples yielded stxϪ/ eae+ strains of the same serotype (tables 1 and 2). Together, this replacement of an stx+/eae+ organism by an stxϪ/eae+ organism of the same serotype in a follow-up stool sample was observed in 6 (28.6%) of 21 patients infected with E. coli O26, 1 (3.3%) of 30 patients infected with SF E. coli O157:NM, but none of 86 patients infected with EHEC strains of other serotypes including O157:H7 (table 1) . Thus, the conversion from stx+ to stxϪ strains was significantly more frequent among E. coli O26 (6 of 21) than among EHEC of all other serogroups combined (1 of 116) ( , by 2-tailed Fisher's exact test), P ! .001 suggesting that the stx prophage may be less stable in EHEC O26 than in other EHEC strains. Of interest, this process occurred independently in all 3 patients who were affected during a small EHEC O26:H11 outbreak [23] (patients A, C, and E; table 2), raising the possibility that stx lability is a function of individual strains. There was free fecal Stx in the initial stool samples but not in the subsequent stool samples (table 2) . Cultures of initial and subsequent stool samples from each of these 7 patients were negative for other bacterial enteric pathogens. Acute-phase serum samples, which were available from 6 of these patients, demonstrated IgM antibodies to cognate (but not heterologous) LPS (table 2) .
Genotypic and phenotypic characteristics of consecutive In contrast, the stx+ and stxϪ SF E. coli O157:NM isolates produced the same fliC RFLP pattern H7 and possessed eae g and EHEC-hlyA genes but did not express the enterohemolytic phenotype. Also, both contained a plasmid-borne sfpA gene encoding a sorbitol-fermenting EHEC fimbriae and the cdtA, cdtB, and cdtC genes encoding CDT-V.
Plasmid profiles and PFGE analysis. The consecutive stx+/ eae+ and stxϪ/eae+ E. coli O26 isolates from patients A, B, C, and E had identical plasmid profiles (both within the same patient and among the patients). In contrast, the consecutive isolates from patient F differed from each other by 2 plasmids (table 3). The stx+ and stxϪ E. coli O26 isolates from patient D shared a 90-kb plasmid, but the stxϪ isolate lacked the 75-kb plasmid that was present in the stx 2 -positive strain (table  3) . PFGE demonstrated that, with a single exception (patient F), the intrapatient stx+/eae+ isolates and the stx+/eaeϪ isolates differed by only 2 or 3 bands. The first isolate and the followup isolate from patient F differed by 17 bands, possibly because of a coinfection. stxϪ E. coli as the only pathogen in patients with HUS. Five of 210 patients with HUS had, in both initial and followup stool samples, E. coli strains that possessed eae but lacked stx 1 and stx 2 genes (table 1). The eae+ isolates from initial and follow-up stool samples from each of these 5 patients belonged to the same serotype (table 1) and shared identical genotypic and phenotypic characteristics (table 4) . Notably, except for stx genes, the genotypic and phenotypic characteristics of these stxϪ/eae+ isolates were identical to those identified in stx+ isolates of the corresponding serotypes. Culture supernatants of these strains were not toxic to Vero cells, suggesting that they did not contain stx genes that might have been undetectable with our PCR protocol. Accordingly, initial and followup stool samples from these patients contained no free fecal Stx, as demonstrated by the Vero cell assay. None of these patients were infected with Salmonella species, Shigella species, Y. enterocolitica, or C. jejuni.
DISCUSSION
Genomic alterations in an infecting pathogen, in the course of an acute infection, have multiple implications. From a diagnostic standpoint, 2 observations are particularly important. First, the timing of the stool sample collection may be critical for finding Stx-producing strains in patients with HUS. Tarr et al. [44] demonstrated that, if the stool samples of patients with HUS were cultured within 6 days after the onset of diarrhea for EHEC O157:H7, the recovery rate was nearly 100%. This rate decreased to 33.3% in stool samples collected 16 days after the onset of diarrhea. In our study, we analyzed stool samples obtained from patients with HUS that were usually collected 17 days after the onset of diarrhea, and we screened the samples for EHEC by the detection of Stxs or stx. At initial examination, 141 (96.6%) of 146 strains were detected using such methods, whereas only 13 (52.0%) of 25 were detected in follow-up stool samples. This confirms a previous report [44] that EHEC are difficult to identify in patients' feces late in illness. It also demonstrates that, in such cases, stx-and Stx-independent procedures are required to detect strains that might have lost their stx genes. An efficient method for the detection of stxϪ/eae+ strains is colony blot hybridization with a probe complementary to the eae conserved region. Although this procedure is labor intensive and time consuming, it is presently used to recover stxϪ/eae+ strains in our laboratories. However, such an approach is not without pitfalls, because it would miss strains of serotypes O91:H21 and O113:H21, which were present in 2 patients in our study. Therefore, a combination of stx and eae probes is required for the colony blot hybridization to identify members of the known spectrum of pathogenic E. coli in patients with HUS. Second, the loss of stx genes in 6 of 21 EHEC O26 and in 1 of 30 SF EHEC O157:NM but in none of 61 EHEC O157:H7 strains suggests that this phenomenon is associated with particular non-O157:H7 serotypes, especially O26:H11/NM. In this context, the finding in a clinical microbiological laboratory of an stxϪ/eae+ E. coli O26 strain in a patient with HUS should lead a treating physician to consider such a patient as potentially infected with an EHEC strain and to follow therapeutic procedures recommended for patients infected with EHEC (e.g., to avoid antibiotic therapy). Of interest, in our study, the tendency of the stx gene loss was correlated with EHEC serogroup rather than with the median time interval between the collection of initial and follow-up stool samples. Indeed, this time interval was shorter (median interval, 6 days) for patients infected with E. coli O26 and O157:NM strains that lost their stx genes (table 2) than it was for all other patients (median interval, 8 days). Although less likely, an alternative to the loss of stx genes by the 6 EHEC O26 and 1 SF O157:NM strains during infection might be that these patients were infected with a mixed population of stx+ and stxϪ strains from the same source and that the stx+ strains overwhelmed the stxϪ strains during the acute phase of the illness but did not persist for as long as the stxϪ strains. Except for the 2 SF E. coli O157:NM strains, all stxϪ/eae+ E. coli strains could be distinguished on enterohemolysin agar. The enterohemolytic phenotype is produced by EHEC hemolysin (EHEC-Hly) [13] . Its structural gene, EHEC-hlyA [13] , was present in each of the stxϪ/eae+ E. coli strains. However, the mechanism underlying its nonexpression in SF E. coli O157: NM is unknown. Therefore, our data demonstrate that EHECHly production is independent of Stx production in stxϪ/eae+ E. coli strains O26:H11 and O145:H28, even though the pro- duction of EHEC-Hly is a useful marker for the detection of EHEC, as proposed by Beutin et al. [31] . From the standpoint of pathogenesis, it is particularly interesting that, in 5 patients with HUS, stxϪ/eae+ E. coli strains were the only pathogens identified. It is possible that these strains could cause disease by a yet-to-be determined Stx-independent mechanism. Alternatively, these organisms might have colonized these patients without being involved in the pathogenesis of the underlying HUS. In some studies, stxϪ/ eae+ E. coli strains have been isolated from healthy infants [26, 43] , but strains of serotype O157:H7/NM were not found, and O26:H11 strains were extremely rare [43] . In view of the instability of the stx genotype that we have demonstrated, it also seems plausible that the stxϪ/eae+ strains might have directly descended from Stx-producing E. coli strains, which had been present in these patients earlier in the infection. In this scenario, they would have lost these loci before our analysis and, as such, would represent isogenic mutants of Stx-producing strains that have replaced the original EHEC strains.
Our data offer an insight into mechanisms of pathogen evolution. Maintaining the phage encoding stx may be lethal to the bacterial host cell. Survival might be favored by loss of the phage, because such stxϪ progeny of stx+ progenitors are less prone to lysis. Mammalian host signals, such as those initiated by hydrogen peroxide, can induce Stx-encoding prophages [45] . By generating stxϪ mutants, a strain can survive without automatically lysing and carrying the burden of toxin production. The loss of stx-encoding phage can thus offer a selective advantage. Molecular typing methods demonstrated the relatedness of the strains within single patients, which suggests that the change in genotype is caused by the loss of relatively little genome. Even though the exact mechanisms by which stx genes are lost are still unclear, these data might explain the genome rearrangement observed by means of PFGE. A spontaneous loss of stx 1 or stx 2 genes by EHEC isolates during laboratory subcultures that resulted in nontoxigenic derivates, can occur in particular non-O157 serotypes [46] , and recently, spontaneous loss of both stx 1 and stx 2 genes in vitro has also been described in an E. coli O157:H7 clinical isolate [47] . We referred to this phenomenon as clonal turnover, which defines changes in clonal composition characterized by an appearance of new clonal genotypes and loss of old ones [46] . Clonal turnover can be the result of selection for a mutant and subsequent clonal replacement within individual patients or of massive genomic rearrangements, producing the appearance of a new clone. The dynamics of these processes and their function in the evolution of these pathogens warrant further investigation. However, compared with the slow clonal turnover in H. pylori [48] [49] [50] , real-time, rapidly emergent mutations occur in enterohemorrhagic E. coli during human infection.
